Pregnancies complicated by asthma are associated with an increased risk of low birth weight. Currently, the mechanisms causing this outcome are unknown. To investigate whether impaired placental function may be a determinant, we measured placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) activity, protein and mRNA, placental CRH mRNA, fetal cortisol, and fetal estriol concentrations at delivery. Asthmatic subjects were classified according to inhaled glucocorticoid intake during pregnancy and compared with a control nonasthmatic group. There was a 25% reduction in neonatal birth weight centile in asthmatic women who did not use inhaled glucocorticoid treatment. This was accompanied by significantly reduced placental 11β-HSD2 activity, significantly increased fetal cortisol, and a trend toward increased placental CRH mRNA and reduced fetal estriol concentrations. The use of inhaled glucocorticoids for treatment was associated with birth weight centile, 11β-HSD2 activity, CRH mRNA, fetal cortisol,...
CITATION STYLE
Murphy, V. E., Zakar, T., Smith, R., Giles, W. B., Gibson, P. G., & Clifton, V. L. (2002). Reduced 11β-Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated with Decreased Birth Weight Centile in Pregnancies Complicated by Asthma. The Journal of Clinical Endocrinology & Metabolism, 87(4), 1660–1668. https://doi.org/10.1210/jcem.87.4.8377
Mendeley helps you to discover research relevant for your work.